Swiss pharmaceutical giant Novartis announced a series of multibillion-dollar deals with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.
Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45 billion.
TreeHouse Foods is buying private label food and beverage company Protenergy Natural Foods for 170 million Canadian dollars (about $150 million).
Cereal maker Post Holdings Inc. is buying fellow packaged food maker Michael Foods Inc. in a $2.45 billion deal that will expand Post's range of products.
Johnson Controls, which makes both automotive and building systems, said Wednesday that it's buying Air Distribution Technologies from the Canada Pension Plan Investment Board for about $1.6 billion.
Zebra Technologies will spend more than $3 billion to buy the enterprise business of Motorola Solutions in a considerable expansion that is both technological and geographical.
Google has bought Titan Aerospace, a maker of solar-powered drones, saying it could help bring Internet access to remote parts of the world as well as solve other problems.
A federal judge in Kansas has set a hearing in the lawsuit against Boeing brought by two unions over pensions and retiree medical benefits.
Mars is buying some of Procter & Gamble's pet food brands for $2.9 billion to help strengthen its pet care business.
Mallinckrodt is buying California-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business.
Nokia has received regulatory approval from Chinese authorities to sell its mobile phone unit to Microsoft Corp., removing one of the last major hurdles to the $7.3 billion deal.
Private equity firm The Blackstone Group will buy industrial products maker Gates Corp. for $5.4 billion, according to Gates' owners.
The Cleveland-based paint company had agreed in 2012 to buy Consorcio Comex in a deal valued at $2.34 billion, including debt, to increase its presence in certain markets.
Two of the world's largest suppliers of building materials announced plans for a "merger of equals" Monday that would create an industry giant with a combined 32 billion euros ($44 billion) in annual revenues.
India's Sun Pharmaceutical Industries is buying troubled generic drug maker Ranbaxy Laboratories in a $4 billion deal, the companies said Monday.
A small group of Milwaukee residents wants to revive part of that proud history by buying Pabst Brewing Co. from a California executive in hopes of returning the brand to its birthplace, possibly as a city-owned brewery.
Solid Concepts Inc. is the biggest independent additive manufacturing service bureau in North America and a partner to RedEye, Stratasys' existing digital manufacturing service business.
Drug maker Actavis Plc plans to expand its reach into Southeast Asia by spending about $100 million to buy Silom Medical Co., a generic pharmaceutical company focused on Thailand.
Daimler AG is acquiring the remaining shares in a lithium-ion battery cell maker from specialty chemical company Evonik Industries AG as it intensifies its focus on electric cars.
Johnson & Johnson has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business.
Marchionne said the merged company will be able to increase production to more than 6 million cars a year, a level he has long said is the minimum for an automaker to compete in the global market.
Beyond games, Zuckerberg said virtual reality headsets might someday be used to enjoy a courtside seat at a basketball game, study in a classroom, consult with a doctor face-to-face or shop in a virtual store. The technology also has social applications, he said.
California-based Fisker planned to build cars at the former General Motors plant, but it filed for bankruptcy protection in November.
Nokia Corp. says the $7.3 billion deal will be delayed until next month because it is still waiting for approval from regulatory authorities in Asia.